Royalty Pharma PLC (RPRX)

Add to Watchlists
Create an Alert
Quickflows
40.33 -0.03  -0.07% NASDAQ Jul 23, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All RPRX News

News

View All Events

Events

Date Type Description
08/19/2021 Dividends 0.17 Normal dividend, declared July 16, 2021 and paid September 15, 2021
08/11/2021 Earnings Results Q2 2021 Earnings Results
08/11/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/24/2021 09:00 EST AGM 2020 Annual General Meeting
05/19/2021 Dividends 0.17 Normal dividend, declared April 15, 2021 and paid June 15, 2021
05/11/2021 Earnings Results Q1 2021 Earnings Results
05/11/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
02/18/2021 Dividends 0.17 Normal dividend, declared January 08, 2021 and paid March 15, 2021
02/17/2021 Earnings Results Q4 2020 Earnings Results
02/17/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 2.195B
Total Expenses (TTM) 731.24M
Net Income (TTM) 972.92M

Balance Sheet View Statement

Total Assets (Quarterly) 15.91B
Total Liabilities (Quarterly) 6.077B
Shareholders Equity (Quarterly) 4.882B

Cash Flow Statement View Statement

Cash from Operations (TTM) 2.090B
Cash from Investing (TTM) -2.597B
Cash from Financing (TTM) 717.98M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings.
  • URL: https://www.royaltypharma.com
  • Investor Relations URL: https://www.royaltypharma.com/investors/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Aug. 11, 2021
  • Last Earnings Release: May. 11, 2021
  • Next Ex-Dividend Date: Aug. 19, 2021
  • Last Ex-Dividend Date: May. 19, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 40.33
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
XPH SPDR® S&P Pharmaceuticals ETF 4.09%
MSKLX Morgan Stanley Inst Discovery L 3.34%
CPOCX Morgan Stanley Insight L 3.33%
PILL Direxion Daily Phrmctcl&MdclBl3XShrsETF 2.94%
IPO Renaissance IPO ETF 2.44%
MSHLX Morgan Stanley Inst Growth L 2.32%
TCPWX Transamerica Capital Growth R6 2.00%
FID3094 Fidelity US Focused Stock Class T5 1.92%
FID7099 Fidelity US Focused Stock P3T5 1.92%
IHE iShares US Pharmaceuticals ETF 1.38%
IBBQ Invesco Nasdaq Biotechnology ETF 1.29%
BIB ProShares Ultra Nasdaq Biotechnology 1.07%

Comparables

Edit
RARE Ultragenyx Pharmaceutical Inc
JNJ Johnson & Johnson
LLY Eli Lilly and Co
MRK Merck & Co Inc
PFE Pfizer Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.